The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
American Brain Tumor Association
8550 W. Bryn Mawr Avenue, Suite 550
Chicago, IL 60631
The American Brain Tumor Association (ABTA) is an independent, non-profit organization founded in 1973. Services include more than 40 publications that address brain tumors, their treatment, and coping with the disease. These publications are written in easy-to-understand language. The materials address brain tumors in all age groups. The association provides free social service consultations by telephone; a mentor ship program for new brain tumor support group leaders; a nationwide database of established support groups; a resource listing of physicians participating in clinical trials; "Connections" pen pal program; regional patient/family meetings held in communities across the country; and ABTA Kids - a web site just for children interested in brain tumors.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.